Investigation of the effects of the chronic administration of some antihypertensive drugs on enzymatic and non-enzymatic oxidant/antioxidant parameters in rat ovarian tissue
article
OA: closed
CC0
Abstract
OBJECTIVE: In this study, effects of chronic antihypertensive drug (clonidine, methyldopa, amlodipine, ramipril, and rilmenidine) treatment on antioxidant-oxidant parameters were investigated in rat ovarian tissue. STUDY DESIGN: Chronic drug administration for 30 days and at the end, biochemical examinations (total glutathione (tGSH), glutathione peroxidase (GPO), glutathione reductase (GR), glutathione s-transferase (GST), superoxide dismutase (SOD), nitric oxide (NO), catalase (CAT), malondialdehyde (MDA), and myeloperoxidase (MPO) analyses) were performed. RESULTS: The levels of glutathione (GSH) and NO, and the activities of GPO, GR, GST, SOD, and CAT were measured the lowest in ramiprile group. Also in ramiprile group, the level of MDA and the activity of MPO was the highest. CONCLUSION: We divided the drugs into four groups according to their biochemical side effect potentials in ovarian tissue: (I) Drugs which have no clear negative effect on ovarian tissue: clonidine, rilmenidine; (II) Drugs which have mild negative effect on ovarian tissue: methyldopa; (III) Drugs which have moderate negative effect on ovarian tissue: amlodipine; (IV) Drugs which have severe negative effect on ovarian tissue: ramipril. These data might be useful in the selection of the least toxic antihypertensive drug in pregnant and/or normal females.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (45)
- doi:10.2165/00003495-200565060-00005 via openalex
- doi:10.1016/s0140-6736(94)92211-x via openalex
- doi:10.1161/01.hyp.0000103630.72812.10 via openalex
- doi:10.1111/j.1530-0277.2008.00860.x via openalex
- doi:10.1111/1523-1747.ep12506462 via openalex
- doi:10.1016/0006-291x(76)90747-6 via openalex
- W206274772 via openalex
- doi:10.1097/01.asn.0000077406.67663.e7 via openalex
- doi:10.1016/j.cbi.2010.03.041 via openalex
- doi:10.1159/000020606 via openalex
- doi:10.1080/09513590802630104 via openalex
- doi:10.1016/s0076-6879(84)05016-3 via openalex
- doi:10.1146/annurev.bi.58.070189.003523 via openalex
- doi:10.1254/jphs.fp0070122 via openalex
- doi:10.1016/j.cbi.2009.03.002 via openalex
- doi:10.1067/mob.2000.107928 via openalex
- doi:10.1007/s00210-007-0151-0 via openalex
- doi:10.1016/j.cbi.2009.08.016 via openalex
- doi:10.1016/0003-2697(68)90092-4 via openalex
- doi:10.1016/s0076-6879(85)13062-4 via openalex
- doi:10.1016/0027-5107(95)00096-8 via openalex
- doi:10.1016/s0076-6879(81)77053-8 via openalex
- doi:10.1007/bf02977367 via openalex
- W2395506224 via openalex
- doi:10.1159/000201464 via openalex
- doi:10.1016/j.cbi.2007.06.040 via openalex
- W4378093335 via openalex
- doi:10.1016/s0272-6386(12)80087-4 via openalex
- doi:10.1093/clinchem/41.6.892 via openalex
- doi:10.1093/clinchem/34.3.497 via openalex
- doi:10.1016/0003-2697(79)90738-3 via openalex
- doi:10.1136/gut.33.1.30 via openalex
- doi:10.1007/s10753-009-9176-5 via openalex
- doi:10.1056/nejm199204023261405 via openalex
- doi:10.1136/gut.34.2.161 via openalex
- doi:10.1093/clinchem/41.6.904 via openalex
- doi:10.1016/j.jep.2005.06.043 via openalex
- doi:10.1016/0002-9343(91)90278-6 via openalex
- doi:10.1016/j.phymed.2005.07.002 via openalex
- doi:10.1079/pns19870003 via openalex
- doi:10.1093/ndt/6.5.378-a via openalex
- doi:10.1016/s0021-9258(18)54167-3 via openalex
- doi:10.1016/0020-7292(88)90070-7 via openalex
- doi:10.1016/s0002-9378(00)99785-0 via openalex
- doi:10.1016/s0005-2728(99)00027-4 via openalex
Source provenance
- openalex
- last seen: 2026-05-11T05:58:56.137231+00:00
License: CC0
· commercial use OK